Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia
Status:
RECRUITING
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
The primary aims of this study is to contrast the effectiveness of CBT-I and pharmacotherapy (lemborexant) compared to placebo on sleep and mental health outcomes in people with insomnia disorder and anxiety/depressive symptoms. In addition, the study will evaluate whether insomnia phenotypes (i.e., +/- 6hrs of sleep) at baseline moderate the effectiveness of the intervention on both sleep and mental health outcomes.
Phase:
NA
Details
Lead Sponsor:
Laval University
Collaborators:
The Royal Ottawa Mental Health Centre Toronto Metropolitan University